Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2023
Improvements in Patient-Reported Outcomes in Relapsed or Refractory Large B-Cell Lymphoma Patients Treated With EpcoritamabTycel Phillips, Pieternella Lugtenburg, Anupama Kalsekar, et al.Plos One|October 25, 2019
Correction: Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER databaseClaire Faltermeier, Timothy Chai, Sharjeel Syed, et al.Plos One|September 26, 2019
Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER databaseClaire Faltermeier, Timothy Chai, Sharjeel Syed, et al.Integrative and Comparative Biology|April 18, 2024
Tracing the Evolutionary Origin of Chordate Somites in the Hemichordate Ptychodera flavaCindy Chou, Ching-Yi Lin, Che-Yi Lin, et al.Journal of Cardiothoracic Surgery|June 19, 2026
Recent perioperative challenges in anesthesia during expansion of heart transplantationAnthony Wang, Nasir Hussain, Amardeep Mudhar, et al.Journal of Vascular and Interventional Neurology|November 30, 2022
Superior cervical ganglion stimulation results in potent cerebral vasoconstriction in swineWi Jin Kim, Hasitha Milan Samarage, David Zarrin, et al.Molecular and Cellular Biology|February 13, 2013
Monoubiquitination of filamin B regulates vascular endothelial growth factor-mediated trafficking of histone deacetylase 7Yu-Ting Su, Chengzhuo Gao, Yu Liu, et al.Clinical Lymphoma, Myeloma & Leukemia|September 3, 2025
Indirect Comparison of Epcoritamab Versus Axicabtagene Ciloleucel in Chimeric Antigen Receptor T-Cell-Eligible and -Naive Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaGilles Salles, Christopher P Fox, Mehdi Hamadani, et al.Future Oncology (London, England)|September 13, 2024
Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionalsAnna Sureda, Shiraz El Adam, Shibing Yang, et al.Inflammatory Bowel Diseases|April 19, 2018
Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel DiseaseMarla C Dubinsky, Raymond K Cross, William J Sandborn, et al.Pageof 6